Dr. Lindsay Rosenwald – Know More About Lindsay Rosenwald

In mid-2009, Cougar’s tender offer expired (more than 20 billion shares or 95 percent of Cougar stock were tendered) and in May 2009, Johnson & Johnson acquired Cougar Biotechnology Inc. for about $893 million or $43 per share. This merger has recently been completed following large investments by Lindsay Rosenwald, MD, of Paramount BioSciences. Although [...]